FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980772029> ?p ?o ?g. }

• W2980772029 endingPage "2418" @default.
• W2980772029 startingPage "2418" @default.
• W2980772029 abstract "Abstract Tannic acid (TA) was a polyphenol that harbors anti-oxidant capacity. A recent report implied that surface coating with TA might blunt thrombosis via altering the structure of fibrinogen. However, the effect of TA on platelet function and in vivo thrombus formation has not been reported. In this study, we showed that TA inhibits PDI activity and attenuates platelet activation. To explore the effects of TA on platelet aggregation, gel-filtered human platelets from healthy human donors were pretreated with TA (10/30/50 μM) or vehicle (0.9% sodium chloride) before being stimulated by various agonists. Turbidity analyses on a Chronolog aggregometer showed that TA dose-dependently inhibited platelet aggregation induced by thrombin, SFLLRN, GYQGQV, collagen, CRP, U46619, and ristocetin. Next, we employed flow cytometry (FACS) to determine the role of TA in platelet activation, including α-granule secretion and integrin activation. Pretreatment of platelets with TA led to significant reductions in surface P-selectin expression and soluble fibrinogen binding, supporting the inhibition of diverse platelet activation pathways. Supportively, platelet spreading on immobilized fibrinogen was significantly suppressed by TA treatment. In addition, cell viability assay with Almar blue agent showed no detrimental impact of TA on the survival of platelets. To ask whether the antiplatelet role of TA might be translated into an antithrombotic efficacy, we tested the effect of TA in both ex vivo and in vivo thrombosis models. Calcein-labeled human whole blood was perfused through microfluidic channels coated with collagen, and adherent platelets were visualized under a fluorescent microscopy. However, treatment with TA suppressed the number of adherent platelets under flow conditions. Moreover, in laser-induced mouse cremaster muscle arteries, administration of TA (5mg/kg) significantly reduced the size of forming thrombi compared with the vehicle. Verification of bleeding risk using tail truncation assay indicated no prolongation of bleeding time in mice receiving TA. Thus, TA shows an antiplatelet effect and may also attenuate thrombus formation. To gain a mechanistic insight to the role of TA in platelet function, we performed a molecular docking screen of the structure of TA and platelet surface proteins using the Autodock Vina software, which displayed the binding of TA with protein disulfide isomerase at the enzymatic active center. We then measured the impact of TA on PDI reductase activity with the dieosin glutathione disulfide assay in vitro (di-GSSG), showing that TA significantly inhibited PDI activity in a concentration-dependent manner. The results were verified in platelets using the 3-(N-Maleimidylpropionyl) biocytin (MPB) labeling, which showed that TA abrogated thrombin-stimulated free thiol formation on platelet surface. Supportively, FACS demonstrated that TA significantly suppressed the binding of fluorescent-labeled PDI to Mn2+-activated platelet integrin β3. Taken together, our findings demonstrated that TA inhibits PDI activity and may become a novel antithrombotic agent. Disclosures No relevant conflicts of interest to declare." @default.
• W2980772029 created "2019-10-25" @default.
• W2980772029 creator A5058712148 @default.
• W2980772029 date "2018-11-29" @default.
• W2980772029 modified "2023-09-28" @default.
• W2980772029 title "Tannic Acid Inhibits Protein Disulfide Isomerase, Platelet Activation and Thrombus Formation" @default.
• W2980772029 doi "https://doi.org/10.1182/blood-2018-99-114418" @default.
• W2980772029 hasPublicationYear "2018" @default.
• W2980772029 type Work @default.
• W2980772029 sameAs 2980772029 @default.
• W2980772029 citedByCount "2" @default.
• W2980772029 countsByYear W29807720292021 @default.
• W2980772029 countsByYear W29807720292022 @default.
• W2980772029 crossrefType "journal-article" @default.
• W2980772029 hasAuthorship W2980772029A5058712148 @default.
• W2980772029 hasBestOaLocation W29807720291 @default.
• W2980772029 hasConcept C126322002 @default.
• W2980772029 hasConcept C150903083 @default.
• W2980772029 hasConcept C178790620 @default.
• W2980772029 hasConcept C185592680 @default.
• W2980772029 hasConcept C202751555 @default.
• W2980772029 hasConcept C207001950 @default.
• W2980772029 hasConcept C26291073 @default.
• W2980772029 hasConcept C2777292125 @default.
• W2980772029 hasConcept C2779036427 @default.
• W2980772029 hasConcept C2779508331 @default.
• W2980772029 hasConcept C2781295650 @default.
• W2980772029 hasConcept C2781393965 @default.
• W2980772029 hasConcept C2910542480 @default.
• W2980772029 hasConcept C3018697912 @default.
• W2980772029 hasConcept C55493867 @default.
• W2980772029 hasConcept C56701166 @default.
• W2980772029 hasConcept C71924100 @default.
• W2980772029 hasConcept C86803240 @default.
• W2980772029 hasConcept C89560881 @default.
• W2980772029 hasConcept C98274493 @default.
• W2980772029 hasConceptScore W2980772029C126322002 @default.
• W2980772029 hasConceptScore W2980772029C150903083 @default.
• W2980772029 hasConceptScore W2980772029C178790620 @default.
• W2980772029 hasConceptScore W2980772029C185592680 @default.
• W2980772029 hasConceptScore W2980772029C202751555 @default.
• W2980772029 hasConceptScore W2980772029C207001950 @default.
• W2980772029 hasConceptScore W2980772029C26291073 @default.
• W2980772029 hasConceptScore W2980772029C2777292125 @default.
• W2980772029 hasConceptScore W2980772029C2779036427 @default.
• W2980772029 hasConceptScore W2980772029C2779508331 @default.
• W2980772029 hasConceptScore W2980772029C2781295650 @default.
• W2980772029 hasConceptScore W2980772029C2781393965 @default.
• W2980772029 hasConceptScore W2980772029C2910542480 @default.
• W2980772029 hasConceptScore W2980772029C3018697912 @default.
• W2980772029 hasConceptScore W2980772029C55493867 @default.
• W2980772029 hasConceptScore W2980772029C56701166 @default.
• W2980772029 hasConceptScore W2980772029C71924100 @default.
• W2980772029 hasConceptScore W2980772029C86803240 @default.
• W2980772029 hasConceptScore W2980772029C89560881 @default.
• W2980772029 hasConceptScore W2980772029C98274493 @default.
• W2980772029 hasIssue "Supplement 1" @default.
• W2980772029 hasLocation W29807720291 @default.
• W2980772029 hasOpenAccess W2980772029 @default.
• W2980772029 hasPrimaryLocation W29807720291 @default.
• W2980772029 hasRelatedWork W1547181084 @default.
• W2980772029 hasRelatedWork W2024261820 @default.
• W2980772029 hasRelatedWork W2077772721 @default.
• W2980772029 hasRelatedWork W2128349065 @default.
• W2980772029 hasRelatedWork W2299926357 @default.
• W2980772029 hasRelatedWork W2554273781 @default.
• W2980772029 hasRelatedWork W2904545963 @default.
• W2980772029 hasRelatedWork W2980772029 @default.
• W2980772029 hasRelatedWork W4238093296 @default.
• W2980772029 hasRelatedWork W4319656861 @default.
• W2980772029 hasVolume "132" @default.
• W2980772029 isParatext "false" @default.
• W2980772029 isRetracted "false" @default.
• W2980772029 magId "2980772029" @default.
• W2980772029 workType "article" @default.